University of Cambridge researchers found that many commercial sweeteners directly alter the growth of human gut bacteria in laboratory tests [1].
These findings suggest that the common practice of consuming artificial sweeteners, often alongside medications, could unintentionally disrupt the microbial balance necessary for digestive and systemic health.
The research team tested 39 commercial sweeteners [1]. They also examined 156 sweetener-drug combinations to investigate how these substances affect the composition and function of the human gut microbiome [2].
The study identified more than 100 cases where sweeteners behaved differently when combined with other substances [1]. Some of these interactions slowed the growth of important bacteria, while others changed how the microbes responded to the environment.
One specific combination proved particularly disruptive. The pairing of the sweetener isosteviol and the antidepressant duloxetine reduced beneficial bacteria and overall microbial diversity [3].
Researchers conducted the study to understand how sweeteners, when mixed with caffeine, flavorings, or medications, influence the gut [2]. The results indicate that the interaction between a sweetener and a secondary substance can create a different biological effect than the sweetener alone.
The laboratory tests provide a baseline for how these chemical interactions occur in a controlled setting [1]. While the results are promising, the team continues to explore the long-term implications of these microbiome shifts.
“More than 100 interaction cases were identified”
This research highlights a potential risk for patients taking specific medications, such as antidepressants, who also consume sugar substitutes. By demonstrating that sweeteners can act as catalysts or inhibitors when paired with drugs, the study suggests that dietary choices may interfere with the efficacy of medical treatments or exacerbate gut dysbiosis.
